FDA advisors unanimously green-light Moderna boosters for folks 65+, high-risk

Words and symbols adorn a large outdoor sign.

Enlarge / The Meals and Drug Administration headquarters in White Oak, Maryland. (credit score: Getty | Congressional Quarterly)

As anticipated, a committee of impartial advisors for the Meals and Drug Administration voted unanimously (19-to-0) Thursday afternoon in favor of authorizing a booster dose of Moderna’s COVID-19 vaccine for sure teams.

The teams flagged for reinforcing are people aged 65 and older, folks ages 18 to 64 who’re liable to extreme COVID-19 attributable to well being issues, and people 18 to 64 who’re liable to COVID-19 attributable to frequent institutional or occupational exposures, comparable to well being care and important employees. These are the identical teams that have been beforehand approved to get a Pfizer/BioNTech booster.

As with the Pfizer/BioNTech boosters, the Moderna boosters are to be given six months or longer after the primary two doses of Moderna’s mRNA vaccine.

Learn 11 remaining paragraphs | Feedback

Related Posts

Leave a Reply

Your email address will not be published.